clot-dissolving drug

(redirected from Thrombolytic drug)
Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Thrombolytic drug: Anticoagulant drug

clot-dissolving drug

Thrombolytic (agent), see there.
References in periodicals archive ?
Thrombus is cleared rapidly and exposure to thrombolytic drugs is reduced or eliminated, but there may be a slightly higher risk of pulmonary embolism and a higher requirement for vena caval filters.
Anti-clotting or thrombolytic drugs save lives and speed patients' recovery by breaking down the blood clots which cause heart attacks.
studies was the thrombolytic drug used; desmoteplase, a plasminogen activator derived from vampire bat saliva.
An exception is a patient older than 75 years, who should not receive a IIb/IIIa inhibitor along with a thrombolytic drug because of the increased risk of intracranial hemorrhage.
Thrombolytic drugs act to break down the blood clot which causes a heart attack, allowing oxygen to get to the heart muscle.
For example, during and after thrombolytic drug administration, a quantifiable measure of a patient's systemic lytic response can be determined rapidly at the POC to verify drug action [5].
Nils Kucher from the University Hospital of Bern (Switzerland), principal investigator of the Ultrasound Accelerated Thrombolysis of Pulmonary Embolism (ULTIMA) trial launched in 2010, emphasized, "Because the EKOS system incorporates into the catheter body small ultrasound transmitters which condition the clot to more rapidly absorb the thrombolytic drug, it can dissolve the clot faster than thrombolytic drug alone.
Patients with an acute MI who received standard lytic therapy and aspirin underwent a repeat ECG 90 minutes after receiving their initial thrombolytic drug.
The percentage of Ischaemic Stroke patients prescribed the thrombolytic drug Tissue Plasminogen Activator (e.
studies was the thrombolytic drug used: desmoteplase, a plasminogen activator derived from vampire-bat saliva.
That's because the new trial, conducted in India, China, Pakistan, and several South American countries and involving 15,570 patients, included only about 100 patients treated with a fibrin-specific thrombolytic drug.
VIENNA -- A radical new approach to treatment of out-of-hospital cardiac arrest--administration of a thrombolytic drug during CPR--will soon be evaluated in an international randomized trial.